Steroid Non-responsive Hashimoto's Encephalopathy Improved by Rituximab
Journal of the Korean Neurological Association
; : 19-21, 2018.
Article
em Ko
| WPRIM
| ID: wpr-766632
Biblioteca responsável:
WPRO
ABSTRACT
Hashimoto's encephalopathy is a rare autoimmune disease, with symptoms of encephalopathy and high titers of serum anti-thyroid antibodies. Current diagnostic criteria include corticosteroid responsiveness, but in some cases, they are refractory to corticosteroids. In steroid non-responders, other immunomodulatory therapies could be applied. Recently, Rituximab is reported as a safe and effective treatment for Hashimoto's encephalopathy. We report a 50-year-old woman with Hashimoto's encephalopathy presented with confusion and catatonia who was refractory to corticosteroid and immunoglobulin but effectively treated with rituximab.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Doenças Autoimunes
/
Hormônios Tireóideos
/
Encefalopatias
/
Imunoglobulinas
/
Catatonia
/
Corticosteroides
/
Imunomodulação
/
Rituximab
/
Glucocorticoides
/
Anticorpos
Limite:
Female
/
Humans
Idioma:
Ko
Revista:
Journal of the Korean Neurological Association
Ano de publicação:
2018
Tipo de documento:
Article